focus -WSS

focus

author：leisure time 2025-09-27 23:01:47 - browse：2

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The dental labor crisis is a moment of opportunity

explore

WSS

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Robert F. Kennedy is pitching centrism on health, even on abortion

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Industry veterans launch new biotech VC with $310M

BioAge raises $170M for combination therapy with Zepbound

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

hotspot

focus

explore

New air purifier tech could be key to improving indoor air quality

Private equity deals in Medicare Advantage declines

After affirmative action ruling, medical educators look to 'holistic review'

Elon Musk announces 'temporary limits' for reading Twitter posts

Heart attack and stroke risk calculators need revising

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: How biotech is using artificial intelligence

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden report: The neurospychology of memory and aging

knowledge

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

What we’ve learned from the Aduhelm mess

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Key House Republican on health care plans exit from Congress

Vaccine advisory panel ACIP left half staffed by HHS

entertainment

focus

explore

hotspot